Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Shock. 2017 Oct;48(4):490–497. doi: 10.1097/SHK.0000000000000886

Figure 3. Iron status and utilization in inflamed WT and HKO mice undergoing early treatment with Fe and/or EPO.

Figure 3

(A) Liver iron. (B) Serum iron. (C) Δ MCV. (D) Spleen weights. The dashed lines represent the mean values from the uninflamed control WT mice of Figure 1. Panels A–C: Treatment groups for each genotype included 5–10 evaluable male mice. Panel D: Treatment groups for WT mice included 3 male mice; Treatment groups for HKO mice included 8–10 male mice. Means ± SD (Panel A) or medians ± 75th/25th percentile (Panels B–D) are shown; *p<0.05 compared to saline group, †p<0.05 and ††p<0.001 compared to genotype counterpart, all by Holm-Sidak method.